Financials WELL Health Technologies Corp.
Equities
WELL
CA94947L1022
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.960 CAD | -0.75% |
|
+2.86% | -42.27% |
| Nov. 26 | Stifel Keeps Buy Rating, $9 Target on Well Health Amid Competition Bureau Investigation | MT |
| Nov. 21 | Stifel Canada on WELL Health Q3 Organic Growth Figures | MT |
Projected Income Statement: WELL Health Technologies Corp.
Annual
Quarterly
Annual
Quarterly
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 50.24 | 302.3 | 569.1 | 776.1 | 919.7 | 1,401 | 1,559 | 1,670 |
| Change | - | 501.76% | 88.25% | 36.36% | 18.51% | 52.38% | 11.22% | 7.16% |
| EBITDA 1 | -0.092 | 60.36 | 104.6 | 113.4 | 46.66 | 199.9 | 208 | 231.3 |
| Change | - | 65,704.83% | 73.22% | 8.45% | -58.85% | 328.38% | 4.06% | 11.18% |
| EBIT 1 | -10.41 | -12.79 | 23.31 | 35.16 | -30.2 | 86.37 | 97.76 | 131 |
| Change | - | -22.92% | 282.23% | 50.82% | -185.89% | 386.04% | 13.19% | 34% |
| Interest Paid 1 | -1.935 | -8.992 | -25.29 | -33.6 | -37.62 | -53 | -48.97 | -40 |
| Earnings before Tax (EBT) 1 | -6.986 | -24.97 | 17.92 | 19.5 | 8.992 | 7.08 | 40.89 | 36 |
| Change | - | -257.47% | 171.76% | 8.79% | -53.88% | -21.26% | 477.48% | -11.95% |
| Net income 1 | -3.686 | -43.79 | 1.369 | 0.082 | 32.61 | -16.27 | 22.25 | 52.17 |
| Change | - | -1,087.78% | 103.13% | -94.01% | 39,667.07% | -149.89% | 236.79% | 134.43% |
| Announcement Date | 3/18/21 | 3/31/22 | 3/21/23 | 3/21/24 | 4/15/25 | - | - | - |
1CAD in Million
Estimates
Forecast Balance Sheet: WELL Health Technologies Corp.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 275 | 244 | 302 | 341 | 521 | 446 | 346 |
| Change | - | - | -11.27% | 23.77% | 12.91% | 52.57% | -14.4% | -22.42% |
| Announcement Date | 3/18/21 | 3/31/22 | 3/21/23 | 3/21/24 | 4/15/25 | - | - | - |
1CAD in Million
Estimates
Cash Flow Forecast: WELL Health Technologies Corp.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| CAPEX 1 | 1.135 | 2.682 | 6.404 | 8.107 | 16.23 | 25.03 | 25.63 | 25.1 |
| Change | - | 136.37% | 138.78% | 26.59% | 100.15% | 54.28% | 2.4% | -2.08% |
| Free Cash Flow (FCF) 1 | -6.517 | 19.59 | 70.14 | 58.33 | -6.704 | 84.16 | 96.98 | 123.6 |
| Change | - | 400.55% | 258.12% | -16.84% | -111.49% | 1,355.37% | 15.23% | 27.5% |
| Announcement Date | 3/18/21 | 3/31/22 | 3/21/23 | 3/21/24 | 4/15/25 | - | - | - |
1CAD in Million
Estimates
Forecast Financial Ratios: WELL Health Technologies Corp.
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
| EBITDA Margin (%) | - | -0.18% | 19.97% | 18.37% | 14.61% | 5.07% | 14.26% | 13.35% | 13.85% |
| EBIT Margin (%) | - | -20.71% | -4.23% | 4.1% | 4.53% | -3.28% | 6.16% | 6.27% | 7.84% |
| EBT Margin (%) | - | -13.91% | -8.26% | 3.15% | 2.51% | 0.98% | 0.51% | 2.62% | 2.16% |
| Net margin (%) | - | -7.34% | -14.48% | 0.24% | 0.01% | 3.55% | -1.16% | 1.43% | 3.12% |
| FCF margin (%) | - | -12.97% | 6.48% | 12.32% | 7.52% | -0.73% | 6.01% | 6.22% | 7.4% |
| FCF / Net Income (%) | - | 176.78% | -44.73% | 5,123.59% | 71,134.15% | -20.56% | -517.35% | 435.82% | 237.03% |
Profitability | |||||||||
| ROA | -9.47% | -2.8% | 0.16% | 1.59% | 1.88% | -0.4% | - | - | - |
| ROE | -36.98% | -2.56% | -6.67% | 2.45% | 2% | 3.28% | - | - | - |
Financial Health | |||||||||
| Leverage (Debt/EBITDA) | - | - | 4.55x | 2.34x | 2.66x | 7.32x | 2.61x | 2.14x | 1.5x |
| Debt / Free cash flow | - | - | 14.02x | 3.48x | 5.17x | -50.94x | 6.19x | 4.6x | 2.8x |
Capital Intensity | |||||||||
| CAPEX / Current Assets (%) | - | 2.26% | 0.89% | 1.13% | 1.04% | 1.76% | 1.79% | 1.64% | 1.5% |
| CAPEX / EBITDA (%) | - | -1,233.17% | 4.44% | 6.12% | 7.15% | 34.77% | 12.52% | 12.32% | 10.85% |
| CAPEX / FCF (%) | - | -17.41% | 13.69% | 9.13% | 13.9% | -242.03% | 29.74% | 26.43% | 20.3% |
Items per share | |||||||||
| Cash flow per share 1 | - | -0.0402 | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - | - |
| Dividend per Share 1 | - | - | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - | - |
| Book Value Per Share 1 | - | - | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - | - |
| EPS 1 | - | -0.03 | -0.23 | - | - | 0.13 | -0.0967 | 0.05 | 0.1767 |
| Change | - | - | -666.67% | - | - | - | -174.36% | 151.72% | 253.34% |
| Nbr of stocks (in thousands) | - | 162,404 | 208,166 | 230,153 | 241,428 | 249,092 | 253,882 | 253,882 | 253,882 |
| Announcement Date | - | 3/18/21 | 3/31/22 | 3/21/23 | 3/21/24 | 4/15/25 | - | - | - |
1CAD
Estimates
| 2025 * | 2026 * | |
|---|---|---|
| P/E ratio | -41x | 79.2x |
| PBR | - | - |
| EV / Sales | 1.09x | 0.93x |
| Yield | - | - |
More valuation ratios
* Estimated data
EPS & Dividend
Y-o-Y evolution of P/E
Sell
Buy

Mean consensus
BUY
Number of Analysts
14
Last Close Price
3.960CAD
Average target price
7.650CAD
Spread / Average Target
+93.18%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- WELL Stock
- Financials WELL Health Technologies Corp.
Select your edition
All financial news and data tailored to specific country editions
















